3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Melanoma
12
Carcinoma, Hepatocellular
11
Carcinoma, Non-Small-Cell Lung
9
Nasopharyngeal Carcinoma
8
Esophageal Squamous Cell Carcinoma
8
Stomach Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
6
Colorectal Neoplasms
5
Breast Neoplasms
5
Uterine Cervical Neoplasms
4
Small Cell Lung Carcinoma
4
Liver Neoplasms
4
Carcinoma, Transitional Cell
4
Triple Negative Breast Neoplasms
3
Sarcoma
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Hypopharyngeal Neoplasms
3
Cholangiocarcinoma
3
Solid Tumor
2
Recurrence
2
Lymphoma
2
Laryngeal Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Renal Cell
2
Advanced Solid Tumor
2
Upper Tract Urinary Carcinoma
1
Thyroid Neoplasms
1
Thymic epithelial tumor
1
Interventions
Fluorouracil
34
Leucovorin
31
Oxaliplatin
25
Irinotecan
19
Capecitabine
13
Folfox protocol
12
Cetuximab
12
Chemotherapy, Adjuvant
11
Bevacizumab
9
Neoadjuvant Therapy
8
Drug Therapy
8
XELOX
7
Laparoscopy
7
Endoscopic Mucosal Resection
5
Colonoscopy
5
Surgical Procedures, Operative
4
Gemcitabine
4
Tegafur
3
Radiotherapy
3
Propofol
3
Preoperative Exercise
3
Panitumumab
3
Fentanyl
3
Curcumin
3
Colectomy
3
Aspirin
3
raltitrexed
2
Surveys and Questionnaires
2
Sodium Chloride
2
Simvastatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Colonic Neoplasms
×
toripalimab
×
Clear all
NCT03985891
2020-12-17
JSFOL
Xiangya Hospital of Central South University
Phase 1/2
Unknown
40 enrolled